Market Place
Sourcing Support
Darolutamide: A Promising Advancement in Prostate Cancer Treatment
07 Jun 2024 //
PRESS RELEASE
Ilaprazole: A New Contender in the Fight Against Gastroesophageal Conditions
03 Jun 2024 //
PRESS RELEASE
Shandong Loncom will be participate in the CPHI China Expo.
03 Jun 2024 //
PRESS RELEASE
Niraparib Tosylate-A Promising Treatment for Ovarian Cancer
18 Jan 2024 //
PRESS RELEASE
Unveiling the Power of Levosimendan: A Breakthrough in Heart Failure Treatment
17 Jan 2024 //
PRESS RELEASE
Congratulations to Shandong on obtaining the CEP certificate for "Lacosamide"
20 Sep 2023 //
PRESS RELEASE
The 2022 GMP & Regulatory Competition of Shandong has been successfully held
20 Sep 2023 //
PRESS RELEASE
The first domestic imitation of Lacosamide Oral Solution is approved.
20 Sep 2023 //
PRESS RELEASE
Shandong Loncom holds Its ninth anniversary flag raising ceremony
20 Sep 2023 //
PRESS RELEASE
Congratulations to Long Nuo Pharma"Lacosamide" for obtaining the CEP certificate
17 Jun 2023 //
PRESS RELEASE
Shandong Langnuo Pharmaceutical Co., Ltd. won the 2022 Dezhou City Award
23 Aug 2022 //
PRESS RELEASE
The 2022 GMP & Regulatory Competition of Lonno Pharma was successfully held
21 Jun 2022 //
PRESS RELEASE
The first imitation of lacosamide oral solution in China was approved
18 Apr 2022 //
PRESS RELEASE
Warm congratulations to Lonno for passing national high-tech certification
28 Apr 2021 //
PRESS RELEASE
Lonno Pharmaceuticals held its 9th anniversary flag-raising ceremony
18 Apr 2021 //
PRESS RELEASE
Shandong Langnuo Pharma Desloratadine raw material drug/oral sol was approved
06 Feb 2021 //
PRESS RELEASE
Shandong Langnuo new drug R&D incubation pilot test and production assessment
11 Feb 2020 //
PRESS RELEASE
Warm congratulations to Lonno for passing on-site inspection of desloratadine
11 Feb 2020 //
PRESS RELEASE
Warm congratulations successful passing of GMP inspection of Lonno`s Lamivudine
07 Feb 2020 //
PRESS RELEASE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.